Microcap Ledger

Tickers · $MYO

Myomo, Inc. $MYO

By Microcap Ledger desk · CIK 0001369290

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
NYSE American
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Headquarters
Boston, MA
Fiscal year end
December 31
Shares outstanding
39,607,854 [10-Q 2026-08-05]
as of 2026-07-31

Sources: [10-K 2026-03-09]

What the company doesAI summary of filing

Myomo, Inc. develops and markets the MyoPro, a wearable myoelectric-controlled upper limb orthosis (brace) designed to help adults and adolescents with neuromuscular disorders and upper limb paralysis improve functional activities. The company generates revenue primarily through direct billing to insurance companies, including Medicare, and through sales to orthotics and prosthetics providers, the Veterans Administration, and international markets. The MyoPro is a custom-fabricated device that uses electromyography technology to detect weak muscle signals and activate motors to enable movement in paralyzed or weakened arms. The company is revenue-generating and holds 35 issued U.S. patents and multiple international patents, with plans to introduce additional products including the MyoPro3 and MyoPal pediatric device. [10-K 2026-03-09]

Segments: MyoPro (Motion G - powered grasp), MyoPro (Motion W - multi-articulated wrist), MyoPro2x, MyoPal (pediatric)

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$21.82M−$7.03M −$4.14M$11.22M[10-Q 2026-08-05]
FY ended Dec 2025$40.93M−$15.60M −$14.51M$14.13M[10-K 2026-03-09]
FY ended Dec 2024$32.55M−$6.20M −$3.29M$24.37M[10-K 2026-03-09]
Quarterly cash burn
−$2.07M
Cash runway Estimate
~16.3 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-0130,245,870[10-Q 2024-11-06]
2025-03-0134,381,125[10-K 2025-03-10]
2025-05-0235,978,922[10-Q 2025-05-07]
2025-08-0537,801,070[10-Q 2025-08-11]
2025-11-0338,435,524[10-Q 2025-11-10]
2026-03-0238,511,715[10-K/A 2026-04-29]
2026-05-0138,638,653[10-Q 2026-05-07]
2026-07-3139,607,854[10-Q 2026-08-05]
Shelf registration
S-3 filed 2024-08-06; declared effective 2024-08-28 [S-3 2024-08-06]

Listing status

Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-09-11Kovelman Harrysell15,488$1.27[4 2026-09-14]
2026-09-02Morris Milton Mayosell15,000$1.41[4 2026-09-04]
2026-08-20Kovelman Harrysell17,250$1.73[4 2026-08-21]
2026-08-07Kovelman Harrygrant55,149—[4 2026-08-11]
2026-08-07Kovelman Harryother22,457$1.42[4 2026-08-11]
2026-08-07Mitchell Micahgrant58,409—[4 2026-08-11]
2026-08-07Mitchell Micahother21,559$1.42[4 2026-08-11]
2026-08-07Gudonis Paul Rgrant146,909—[4 2026-08-11]
2026-08-07Henry David Agrant68,644—[4 2026-08-11]
2026-08-07Henry David Aother25,310$1.42[4 2026-08-11]
2026-07-13Henry David Aother5,166$1.09[4 2026-07-13]
2026-07-10Henry David Agrant7,840—[4 2026-07-13]

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.